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Abstract
Background: Quality of life (QoL) has become increasingly important in cancer treatment. It refers to the patient’s 
perception of the effects of the disease and therapy, and their impact on daily functioning and general feeling of 
well being.
Material and Methods: In this prospective study, a total of 100 patients treated at our institution, completed the 
European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire and the specific 
EORTC QLQ-H&N35 module. The questionnaires were distributed to the patients between 12 and 60 months 
postoperatively. 
Results: Global QoL score was 58.3 and mean score for functioning scale was 76.7. Fatigue (28.7 ± 26.1), followed 
by financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5)  and pain (26.3 ± 29.9) had highest symptom score on 
QLQ-C30. Fatigue (r=-0.488), insomnia (r=-0.416) and pain (r =-0.448) showed highest value for significantly 
negative correlation to global QoL. In the H&N35 module, restriction of mouth opening (43.3 ± 38.6), dry mouth 
(40.7 ± 36.9), sticky saliva (37.3 ± 37.1) and eating in public (33.8 ± 31.9) were the four worst symptoms. Swal-
lowing problem (r=-0.438), eating in public (r=-0.420) and persistent severe speech (r=-0.398) ranked as the three 
worst symptoms with highest value for significantly negative correlation to global QoL.
Conclusions: Longterm QoL after oncologic surgery and microvascular free flap reconstruction in patients with 
oral cancer is satisfactory. Measuring QoL should be considered as part of the evaluation of cancer treatment.
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Introduction
Generally, the evaluation of cancer treatment is focused 
on the survival rate, local control rate, or complication 
rate. The main disadvantage is that these endpoints 
were usually assessed from the physician s´ points of 
view. Therefore quality of life (QoL) has become in-
creasingly important in cancer therapy. It refers to the 
patient’s perception of the effects of the disease and the 
impact of the operation on the patient’s daily function-
ing. Due to debilitating problems with swallowing and 
speech as well as the psychological effects of loss of 
function and change in body image, QoL present a de-
cisive role in patients with oral cancer (1). Numerous of 
well-validated QoL instruments are established in the 
field of oncology. Especially, the European Organiza-
tion of Research and Treatment of Cancer Quality of 
Life Core Questionnaire C30 (EORTC QLQ-C30) and 
the Quality of Life Head and Neck module (EORTC 
QLQ-H&N35) were frequently used (2,3). Prospective 
QoL studies on patients suffering from head and neck 
cancer with more than 12 months of follow-up are rare 
in the current literature (4,5). The aim of this prospec-
tive study was to evaluate long-term QoL after oncolog-
ic surgery and immediate microvascular reconstruction 
in patients with oral cancer.
Material and Methods
- Study population
The prospective study was initiated after the local eth-
ics committee of the Jena University Hospital gave its 
approval. Written informed consent was obtained from 
all participants. All patients had histological confirmed 
diagnoses of oral squamous cell carcinoma (OSCC) 
and underwent surgery at the Jena University Hospital 
with curative intent. After intraoral radical resection 
and lymph node surgery in accordance with preopera-
tive clinical and radiological examination, all patients 
received immediate microvascular free flap reconstruc-
tion.
- Assessment of QoL
Patients completed the German versions of the EORTC 
QLQ-C30 and the EORTC QLQ-H&N35 at between 12 
and 60 months after treatment. 
The EORTC QLQ-C30 consisted of five functional 
scales (physical function, cognitive function, role func-
tion, emotional function and social function), three 
symptom scales (fatigue, emesis and  pain), one scale 
for the overall health status/QoL and six single items 
(breathing, sleep disorders, appetite loss, constipation, 
diarrhea and economic sequelae) (3). 
The EORTC QLQ-H&N35 comprises seven multi-item 
scales (pain, swallowing, senses, speech, social eating, 
social contact, sexuality) and eleven single items. All 
scales and single item variables were transformed into a 
score from 0 to 100 (2).
A high score for the functioning scale and for the glob-
al QoL scale represents a better level of functioning, 
whereas higher levels in the symptom scales or the sin-
gle-item scales of the EORTC QLQ-C30 and the H&N 
module denotes a high level of symptoms or problems.  
- Statistical analysis
Statistical analyses were conducted using the SPSS/PC 
statistical program (version 22.0 for Windows; SPSS, Inc., 
Chicago, IL). Using the Pearson’s correlation coefficient 
(r), we investigated the potential relationships between 
QoL global score and general, head and neck symptoms. 
In general, r > 0 indicates positive relationship, r < 0 
indicates negative relationship, while r = 0 indicates no 
relationship (or that the variables are independent and 
not related). The strength of relationship is strong for 
value of r -1.0 to -0.5 or 0.5 to 1.0, moderate for value of 
-0.5 to -0.3 or 0.3 to 0.5, weak for value of -0.3 to -0.1 
or 0.1 to 0.3 and none or very weak for value of -0.1 to 
0.1. It is well recognised that a correlation between two 
variables exists when r is superior to 0.3 and that this 
correlation increases as r approaches 1 (6).
Levels of statistical significance have been calculated at 
the 5% level of probability (p <0.05).
Results
A total of 100 patients (69 male, 31 female), mean age 
60.1±11.2 years (range 40-83 years), were enrolled in this 
study. The location of the tumour and the stage of disease 
are shown in table 1. In the majority of cases (42 %), the 
Clinical characteristics
Number of
cases (n = 100) 
Tumour-site
Oral floor 42 
Tongue 23
Lower jaw 14
Upper jaw 13
Buccal mucosa 5
Soft palate 3
UICC-stage
I 39
II 28
III 10
IV 23
Operation
Radial forearm flap 62
Scapular flap 34
Lateral upper arm flap 3
Latissimus dorsi flap 1
Table 1. Clinical characteristics of the 100 patients.
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tumour was located on the floor of the mouth and 67 out of 
100 patients presented with an early stage I/II of disease. 
The radial forearm flap was most commonly used (Table 
1). In all, adjuvant therapy was indicated in 74 cases. 59 
Patients underwent postoperative radiotherapy and further 
15 patients received postoperative radiochemotherapy. 
- EORTC QLQ-C30
The results of the functional scales are shown in table 
2. The mean QoL global score was 58.3 and the mean 
score for functioning scale of 76.7.
The results of the general symptom scales and the bivariate 
analyses between global QoL score and general symptoms 
are shown in table 3. Fatigue (28.7 ± 26.1), followed by fi-
nancial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) and 
pain (26.3 ± 29.9) were the main general complaints.
- Global QoL score was 
• significantly (p<0.05) negative correlated with dysp-
nea (r=-0.250) and financial difficulties (r=-0.212) 
• very significantly (p<0.01) negative correlated with 
fatigue (r=-0.488), nausea (r=-0.364), pain (r =-0.488), 
insomnia (r=-0.416), appetite loss (r=-0.388), and diar-
rhea (r=-0.262).
However, global QoL score was not correlated with 
constipation.
- EORTC QLQ-H&N35
The results from the EORTC QLQ-H&N35 scales and 
items are shown in table 4. Restriction of mouth open-
ing (43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva 
(37.3 ± 37.1) and eating in public (33.8 ± 31.9 ) ranked as 
the four worst symptoms.
- Global QoL score was 
• significantly (p<0.05) negative correlated with prob-
lems with pain medication (r=-0.207), food supplements 
(r=-0.237) and weight loss (r=-0.203).
• very significantly (p<0.01) negative correlated with 
pain (r=-0.385), swallowing (r=-0.438), speech (r=-
0.398), social eating (r=-0.420), social contact (r=-
Functional scales Scores
Global QoL 58.3 ± 22.1 
Physical functioning 81.3 ± 20.4
Role functioning 68.3 ± 31.5
Emotional functioning 72.0 ± 26.3
Cognitive functioning 84.5 ± 21.1
Social functioning 77.3 ± 28.0
Table 2. Results of the QLQ-C30 overall health status and 
functional scales.
*p<0.05; **p<0.01.
Scales Scores r-QoL p-value
Fatigue 28.7 ± 26.1 -0.488** <0.01 
Nausea/
vomiting 
6.7 ± 16.6 -0.364** <0.01 
Pain 26.3 ± 29.9 -0.448** <0.01 
Dyspnea 16.7 ± 27.4 -0.250* 0.012 
Insomnia 26.7 ± 34.5 -0.416** <0.01 
Appetite loss 13.7 ± 25.6 -0.388** <0.01 
Constipation 9.0 ± 24.1 -0.195 0.052 
Diarrhea 6.3 ± 19.4 -0.262** <0.01 
Financial diffi-
culties 
27.7 ± 33.5 -0.212* 0.034 
Table 3. Results of the QLQ-C30 and the bivariate analyses be-
tween QoL score and general symptoms (r-QoL).
Table 4. Results of the QLQ-H&N35 and the bivariate analyses 
between QoL score and symptoms (r-QoL).
Variable Scores r-QoL p-value
Pain 20.7 ± 22.4 -0.385** <0.01
Swallowing 23.4 ± 25.4 -0.438** <0.01
Senses 20.5 ± 26.8 -0.147 0.145 
Speech 25.6 ± 26.2 -0.398** <0.01
Social eating 
33.8 ± 31.9. 
± 31,26,9 
-0.420** <0.01
Social contact 12.9 ± 20.4 -0.405** <0.01
Sexual problems 31.2 ± 37.6 -0.312** <0.01
Teeth 17.0 ± 29.4 -0.112 0.266 
Open mouth 43.3 ± 38.6 -0.391** <0.01
Dry mouth 40.7 ± 36.9 -0.186 0.064 
Sticky saliva 37.3 ± 37.1 -0.175 0.082 
Cough 22.0 ± 28.1 -0.257** <0.01 
Feeling ill 20.1 ± 29.9 -0.412** <0.01
Pain medication 10.0 ± 15.4 -0.207* 0.039 
Food supplement 6.0 ± 12.9 -0.237* 0.018 
Feeding tube 6.3 ± 13.1 -0.184 0.068 
Weight loss 6.3 ± 13.1 -0.203* 0.043 
Weight gain 9.0 ± 14.9 -0.060 0.555 
*p<0.05; **p<0.01 
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0.405), sexual problems (r=-0.312), open mouth (r=-
0.391), cough (r=-0.257) and feeling ill (r=-0.412).
There was no correlation between global QoL and prob-
lems with senses, teeth, dry mouth, sticky saliva, feed-
ing tube and weight gain.
Discussion
QoL has become a increasingly important in the assess-
ment of any therapy in oncology. There is a rapidly in-
creasing number of published studies investigating QoL 
in patients with head and neck cancer (2,5-8). Mean-
while numerous of well-validated QoL instruments are 
now available which have been categorized in three 
types of methods.The first category includes the ge-
neric type, e.g. the Short Form-36 (SF-36), the second 
the cancer specific type, e.g. the Functional Assessment 
of Cancer Treatment (FACT-G), the EORTC QLQ-C30, 
and the third the cancer site-specific type, e.g. the head 
and neck modules in EORTC QLQ-H&N35, and FACT 
(FACT-HN) (2,3,9-11). 
Microvascular free tissue transfers have been used 
routinely for head and neck reconstruction in order 
to improve the functional and esthetic outcomes (6). 
Therefore, the aim of the present study was to evaluate 
long-term QoL after surgery and immediate free flap 
reconstruction in patients with OSCC.
We used a general QoL questionnaire, adapted to all can-
cer patients, the EORTC QLQ-C30, and a specific ques-
tionnaire, the EORTC QLQ-H&N35 which were com-
pleted at between 12 and 60 months after treatment. 
Studies showed that surgical treatment of oral cancer 
led to a temporary deterioration of QoL issues. How-
ever, the levels of these scores improved until the end of 
the first postoperative year (7,12). In addition, there are 
not any further changes in QoL in the follow years after 
treatment (13). Therefore,  it is generally accepted that 
QoL at one year post-treatment is a good indicator of 
QoL at long term in disease-free head and neck cancer 
patients (14,15). 
With a global QoL score close to 60 %, long-term QoL 
of our patients was comparable to the study from Wan 
Leung et al. (1). Meanwhile other authors refer to a glob-
al QoL score close to 70 % (6,16). Furthermore the mean 
score for functioning scale of 76.7 % was similar to the 
results from Pierre et al. with a mean score of 82.5 % 
(6). Overall, persistent fatigue (28.7 ± 26.1) , followed by 
financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) 
and pain (26.3 ± 29.9) were the main general complaints 
of our patients and significantly negative correlated 
with global QoL (fatigue: r=-0.488, financial problems: 
r=-0.212, insomnia: r=-0.416, pain: r=-0.448). Pierre et 
al. and Wan Leung et al. corroborated these results, as 
they also refer that fatigue and insomnia are the main 
general symptoms (6,1). 
In the H&N35 module restriction of mouth opening 
(43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva (37.3 
± 37.1) and eating in public (33.8 ± 31.9) denote a high 
level of problems. The limitation of mouth opening can 
be induced by surgical treatment (17,18). Furthermore 
the adjuvant radiotherapy is responsible for the limita-
tion of mouth opening long term after treatment and for 
salivary dysfunction (19-22). Swallowing problem (r=-
0.438), persistent severe speech (r=-0.398) and eating in 
public (r=-0.420) were significantly negative correlated 
with global QoL. These complaints should be properly 
identified in order to rehabilitate and nutritionally sup-
port patients. Therefore a nutritionist and a rehabilita-
tion therapist should be part of the multidisciplinary 
team planning the care of these patients (8). Further-
more, studies reported that that QoL of patients with 
OSCC can benefit from psychological group therapy 
and psychoeducational treatment (23,24).
Feeling ill (r=-0.412) and pain (r=-0.385) were also sig-
nificantly negative correlated with global QoL. Chronic 
pain is often a consequence of neck dissection and com-
mon after surgical treatment (25). Terrell et al. reported 
that neck dissection is associated with significant decline 
in global QoL (26). Postoperative rehabilitation should in-
corporated in the standard management in these patients. 
Pfister et al. found a significant reduction in pain and 
dysfunction in patients undergoing neck dissection who 
received weekly acupuncture versus usual care (27). 
The design of the current study has some limitations. 
We did not subclassify the patients according to the 
adjuvant therapy. However, the size of the subgroup 
of patients with surgery alone and postoperative ra-
diochemotherapy was too small and inhomogeneous for 
comparison of surgical and combined therapy. Further-
more, the focus of this study was to evaluate the effect 
of immediate microvascular free flap reconstruction on 
long-term QoL. 
Conclusions
The results of the present evaluation with the EORTC 
instruments show that longterm QoL after tumor resec-
tion and immediate microvascular free flap reconstruc-
tion in patients with OSCC seems to be acceptable. The 
highest symptom score on QLQ-C30 was for fatigue, 
followed by financial problems, insomnia and pain. In 
the H&N35 module, restriction of mouth opening, dry 
mouth, sticky saliva and eating in public ranked as the 
four worst symptoms. Measuring QoL should be con-
sidered as part of the evaluation of cancer treatment.
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